$-0.46 EPS Expected for iRhythm Technologies, Inc. (IRTC); Neophotonics (NPTN) Sentiment Is 1.32

NeoPhotonics Corporation (NYSE:NPTN) Logo

Neophotonics Corp (NPTN) investors sentiment decreased to 1.32 in 2018 Q3. It’s down -0.12, from 1.44 in 2018Q2. The ratio dived, as 41 investment managers increased and opened new equity positions, while 31 sold and reduced equity positions in Neophotonics Corp. The investment managers in our database reported: 26.11 million shares, up from 25.22 million shares in 2018Q2. Also, the number of investment managers holding Neophotonics Corp in top ten equity positions increased from 0 to 2 for an increase of 2. Sold All: 9 Reduced: 22 Increased: 24 New Position: 17.

Analysts expect iRhythm Technologies, Inc. (NASDAQ:IRTC) to report $-0.46 EPS on February, 13.They anticipate $0.02 EPS change or 4.17% from last quarter’s $-0.48 EPS. After having $-0.43 EPS previously, iRhythm Technologies, Inc.’s analysts see 6.98% EPS growth. The stock decreased 2.37% or $1.94 during the last trading session, reaching $79.98. About 158,180 shares traded. iRhythm Technologies, Inc. (NASDAQ:IRTC) has risen 37.91% since January 14, 2018 and is uptrending. It has outperformed by 37.91% the S&P500. Some Historical IRTC News: 24/04/2018 – LAKEWOOD CAPITAL RECENTLY SHORTED LIGAND, IRHYTHM: 1Q LETTER; 10/03/2018 – IRTC: ZIO IMPROVES DETECTION OF UNDIAGNOSED ATRIAL FIBRILLATION; 02/05/2018 – IRHYTHM TECHNOLOGIES RAISES GUIDANCE FOR FULL YEAR 2018; 10/03/2018 – Zio by iRhythm Shown to Improve Detection of Previously Undiagnosed Atrial Fibrillation; 02/05/2018 – IRhythm Technologies 1Q Rev $30.6M; 10/04/2018 – IRhythm Technologies Appoints C. Noel Bairey Merz, M.D. to Its Bd of Directors; 10/04/2018 – iRhythm Technologies Appoints UCLA and Cedars-Sinai Professor C. Noel Bairey Merz, M.D. to its Board of Directors; 10/04/2018 – IRhythm Closes Above 50-Day Moving Average: Technicals; 16/05/2018 – JAMA Cardiology publishes RHYTHM Study Revealing Link Between Total AF Burden and Stroke Risk; 15/05/2018 – Polar Capital Buys New 1.4% Position in iRhythm

Analysts await NeoPhotonics Corporation (NYSE:NPTN) to report earnings on March, 7. They expect $-0.11 earnings per share, up 64.52% or $0.20 from last year’s $-0.31 per share. After $-0.12 actual earnings per share reported by NeoPhotonics Corporation for the previous quarter, Wall Street now forecasts -8.33% EPS growth.

The stock decreased 0.97% or $0.07 during the last trading session, reaching $7.11. About 410,565 shares traded. NeoPhotonics Corporation (NPTN) has declined 1.07% since January 14, 2018 and is downtrending. It has underperformed by 1.07% the S&P500. Some Historical NPTN News: 09/05/2018 – NeoPhotonics Presenting at Conference May 24; 08/05/2018 – NeoPhotonics Sees 2Q Rev $70M-$76M; 17/04/2018 – NEOPHOTONICS – CO PROVIDES COMPONENT PRODUCTS TO SOME ZTE SUPPLY CHAIN PARTNERS WHICH IS ESTIMATED IN 2017 TO HAVE BEEN ABOUT 3% OF TOTAL REV; 08/05/2018 – NeoPhotonics Sees 2Q Loss/Shr 34c-Loss 24c; 08/05/2018 – NeoPhotonics Sees 2Q Adj Loss/Shr 26c-Adj Loss/Shr 16c; 27/03/2018 – NeoPhotonics (NPTN) on Watch Amid Chatter; 17/04/2018 – NEOPHOTONICS:DIRECT REV. FROM ZTE IN FY2017 WAS 1% OF TOTAL REV; 21/04/2018 – DJ NeoPhotonics Corporation, Inst Holders, 1Q 2018 (NPTN); 17/04/2018 – NeoPhotonics Reveals Effect Of ZTE Export Ban On Revenue — MarketWatch; 17/04/2018 – NeoPhotonics Direct Rev From ZTE During Fiscal Yr 2017 Was Approximately 1% of Total Rev

Cooper Creek Partners Management Llc holds 5.69% of its portfolio in NeoPhotonics Corporation for 1.06 million shares. Awm Investment Company Inc. owns 2.37 million shares or 3.25% of their US portfolio. Moreover, White Pine Capital Llc has 1.06% invested in the company for 358,905 shares. The New York-based Springowl Associates Llc has invested 0.77% in the stock. Northpointe Capital Llc, a Michigan-based fund reported 437,348 shares.

NeoPhotonics Corporation develops, manufactures, and sells hybrid photonic integrated optoelectronic products that transmit, receive, and switch high speed digital optical signals for communications networks. The company has market cap of $327.41 million. It offers high speed products, including transmitter, receiver, and switching products for 100G and optical transmission applications over distances of 2 to 2,000 kilometers; and optical components for coherent systems, including narrow linewidth tunable transmit and local oscillator lasers (NLW-ITLA) that generates ultra-pure wavelength or color for coherent transmission, as well as integrated coherent receivers (ICRs), which decodes the phase and polarization encoded coherent signals. It currently has negative earnings. The firm also engages in developing pluggable coherent modules that combine NLW-ITLA with ICR and a coherent modulator; and offers 100G products for the client side and datacenter applications.

Since January 1, 0001, it had 0 insider buys, and 3 selling transactions for $292,923 activity.

More notable recent iRhythm Technologies, Inc. (NASDAQ:IRTC) news were published by: Nasdaq.com which released: “Research Published in Nature Medicine Demonstrates the Promise of Algorithm-Based Ambulatory Cardiac Monitoring – Nasdaq” on January 07, 2019, also Nasdaq.com with their article: “iRhythm Technologies to Present at the JP Morgan 37th Annual Healthcare Conference – Nasdaq” published on December 19, 2018, Benzinga.com published: “IRhythm (NASDAQ:IRTC) Still Kicking After Shock Of Apple (NASDAQ:AAPL) Competition – Benzinga” on September 13, 2018. More interesting news about iRhythm Technologies, Inc. (NASDAQ:IRTC) were released by: Globenewswire.com and their article: “iRhythm Technologies Announces Third Quarter Financial Results – GlobeNewswire” published on October 30, 2018 as well as Globenewswire.com‘s news article titled: “iRhythm Technologies Announces Second Quarter Financial Results – GlobeNewswire” with publication date: August 01, 2018.

NeoPhotonics Corporation (NYSE:NPTN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.